Manufacturer-Perceived Development and Market-Entry Risks Associated with Discontinuation and Non-launch of Generic Medicines in Japan: A Cross-Sectional Survey of Marketing Authorization Holders.

Mamiya H, Tagoku H, Izutsu KI.

Open source

DOI
10.1007/s40290-026-00636-8
Published
2026-09-14
Container
Pharmaceut Med
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40290-026-00636-8,
  title = {Manufacturer-Perceived Development and Market-Entry Risks Associated with Discontinuation and Non-launch of Generic Medicines in Japan: A Cross-Sectional Survey of Marketing Authorization Holders.},
  author = {Mamiya H and  Tagoku H and  Izutsu KI.},
  year = {2026},
  journal = {Pharmaceut Med},
  doi = {10.1007/s40290-026-00636-8},
  url = {https://doi.org/10.1007/s40290-026-00636-8}
}

RIS

TY  - JOUR
TI  - Manufacturer-Perceived Development and Market-Entry Risks Associated with Discontinuation and Non-launch of Generic Medicines in Japan: A Cross-Sectional Survey of Marketing Authorization Holders.
AU  - Mamiya H
AU  -  Tagoku H
AU  -  Izutsu KI.
PY  - 2026
JO  - Pharmaceut Med
DO  - 10.1007/s40290-026-00636-8
UR  - https://doi.org/10.1007/s40290-026-00636-8
ER  - 

APA

H, M., H, T., & KI., I. (2026). Manufacturer-Perceived Development and Market-Entry Risks Associated with Discontinuation and Non-launch of Generic Medicines in Japan: A Cross-Sectional Survey of Marketing Authorization Holders.. Pharmaceut Med. https://doi.org/10.1007/s40290-026-00636-8

Source records